Linear amplification mediated PCR - Localization of genetic elements and characterization of unknown flanking DNA

Journal of Visualized Experiments

Volumn , Issue 88, 2014, Pages

  Gabriel, Richard ^a   Kutschera, Ina ^a   Bartholomae, Cynthia C ^a   von Kalle, Christof ^a   Schmidt, Manfred ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

AAV; Clonal inventory; Deep sequencing; Gene therapy; Genetics; Integration site analysis; Integrome; Issue 88; LAM PCR; Lentiviral vectors; Mutagenesis screen; Retroviral vectors

Indexed keywords

DNA;

ANALYSIS; GENE VECTOR; GENETICS; HIGH THROUGHPUT SEQUENCING; LENTIVIRINAE; POLYMERASE CHAIN REACTION; PROCEDURES; RETROVIRIDAE;

DNA; GENETIC VECTORS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; LENTIVIRUS; POLYMERASE CHAIN REACTION; RETROVIRIDAE;

EID: 84903398960     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/51543     Document Type: Article

References (30)

1. Schmidt, M. et al. Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum Gene Ther. 12, 743-749 doi:10.1089/104303401750148649 (2001).
2. Schmidt, M. et al. High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat Methods. 4, 1051-1057 doi:nmeth1103 [pii] 10.1038/nmeth1103 (2007).
3. Schroeder, A. R. et al. HIV-1 integration in the human genome favors active genes and local hotspots. Cell. 110, 521-529 (2002).
4. Wu, X., Li, Y., Crise, B., & Burgess, S. M. Transcription start regions in the human genome are favored targets for MLV integration. Science. 300, 1749-1751 (2003).
5. Vigdal, T. J., Kaufman, C. D., Izsvak, Z., Voytas, D. F., & Ivics, Z. Common physical properties of DNA affecting target site selection of sleeping beauty and other Tc1/mariner transposable elements. J Mol Biol. 323, 441-452 doi:S0022283602009919 [pii] (2002).
6. Lewinski, M. K. et al. Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog. 2, e60 doi:06-PLPA-RA-0089R1 [pii] 10.1371/journal.ppat.0020060 (2006).
7. Mueller, P. R., & Wold, B. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science. 246, 780-786 (1989).
8. Silver, J., & Keerikatte, V. Novel use of polymerase chain reaction to amplify cellular DNA adjacent to an integrated provirus. Journal of virology. 63, 1924-1928 (1989).
9. Gabriel, R. et al. Comprehensive genomic access to vector integration in clinical gene therapy. Nature medicine. 15, 1431-1436 doi:nm.2057 [pii] 10.1038/nm.2057 (2009).
10. Harkey, M. A. et al. Multiarm high-throughput integration site detection: limitations of LAM-PCR technology and optimization for clonal analysis. Stem Cells Dev. 16, 381-392 doi:10.1089/scd.2007.0015 (2007).
11. Wang, G. P. et al. DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer. Nucleic acids research. 36, e49 doi:gkn125 [pii] 10.1093/nar/gkn125 (2008).
12. Paruzynski, A. et al. Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing. Nat. Protocols. 5, 1379-1395 (2010).
13. Hacein-Bey-Abina, S. et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest118, 3132-3142 doi:10.1172/JCI35700 (2008).
14. Hacein-Bey-Abina, S. et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 302, 415-419 (2003).
15. Howe, S. J. et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest118, 3143-3150 doi:10.1172/JCI35798 (2008).
16. Cartier, N. et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science. 326, 818-823 doi:326/5954/818 [pii] 10.1126/science.1171242 (2009).
17. Matrai, J. et al. Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk. Hepatology. 53, 1696-1707 doi:10.1002/hep.24230 (2011).
18. Penaud-Budloo, M. et al. Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle. Journal of virology. 82, 7875-7885 doi:10.1128/JVI.00649-08 JVI.00649-08 [pii] (2008).
19. Kaeppel, C. et al. A largely random AAV integration profile after LPLD gene therapy. Nature medicine. 19, 889-891 doi:10.1038/nm.3230 nm.3230 [pii] (2013).
20. Voigt, K. et al. Retargeting sleeping beauty transposon insertions by engineered zinc finger DNA-binding domains. Mol Ther. 20, 1852-1862 doi:10.1038/mt.2012.126 mt2012126 [pii] (2012).
21. Yanez-Munoz, R. J. et al. Effective gene therapy with nonintegrating lentiviral vectors. Nature medicine. 12, 348-353 doi:nm1365 [pii] 10.1038/nm1365 (2006).
22. Boztug, K. et al. Stem-Cell Gene Therapy for the Wiskott-Aldrich Syndrome. N Engl J Med. 363, 1918-1927 doi:10.1056/NEJMoa1003548 (2010).
23. Deichmann, A. et al. Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy. J Clin Invest. 117, 2225-2232 doi:10.1172/JCI31659 (2007).
24. Schwarzwaelder, K. et al. Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo. J Clin Invest. 117, 2241-2249 doi:10.1172/JCI31661 (2007).
25. Gabriel, R. et al. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol. 29, 816-823 doi:10.1038/nbt.1948 nbt.1948 [pii] (2011).
26. Dieter, S. M. et al. Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell. 9, 357-365 doi:10.1016/j.stem.2011.08.010 S1934-5909(11)00391-2 [pii] (2011).
27. Montini, E. et al. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nature biotechnology. 24, 687-696 (2006).
28. Zavidij, O. et al. Stable long-term blood formation by stem cells in murine steady-state hematopoiesis. Stem Cells. 30, 1961-1970 doi:10.1002/stem.1151 (2012).
29. Martins, V. C. et al. Thymus-autonomous T cell development in the absence of progenitor import. J Exp Med. 209, 1409-1417 doi:10.1084/jem.20120846 jem.20120846 [pii] (2012).
30. Arens, A. et al. Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites. Hum Gene Ther Methods. 23, 111-118 doi:10.1089/hgtb.2011.219 [pii] 10.1089/hgtb.2011.219 (2012).